Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Personalized radiotherapy treatment planning based on functional imaging.

Skórska M, Piotrowski T.

Rep Pract Oncol Radiother. 2017 Jul-Aug;22(4):327-330. doi: 10.1016/j.rpor.2017.04.002. Epub 2017 May 15. Review.

PMID:
28663715
2.

Molecular mechanisms of hypoxia in cancer.

Challapalli A, Carroll L, Aboagye EO.

Clin Transl Imaging. 2017;5(3):225-253. doi: 10.1007/s40336-017-0231-1. Epub 2017 May 11. Review.

3.

Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features.

Seo M, Ryu JK, Jahng GH, Sohn YM, Rhee SJ, Oh JH, Won KY.

Korean J Radiol. 2017 Jan-Feb;18(1):238-248. doi: 10.3348/kjr.2017.18.1.238. Epub 2017 Jan 5.

4.
5.

Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases.

Nayak TR, Andreou C, Oseledchyk A, Marcus WD, Wong HC, Massagué J, Kircher MF.

Nanoscale. 2017 Jan 19;9(3):1110-1119. doi: 10.1039/c6nr08217c.

PMID:
27991632
7.

Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment.

Elkashef SM, Allison SJ, Sadiq M, Basheer HA, Ribeiro Morais G, Loadman PM, Pors K, Falconer RA.

Sci Rep. 2016 Sep 9;6:33026. doi: 10.1038/srep33026.

8.

Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer.

Choi HY, Ko ES, Han BK, Kim EJ, Kim SM, Lim Y, Kim RB.

PLoS One. 2016 Jul 6;11(7):e0158500. doi: 10.1371/journal.pone.0158500. eCollection 2016.

9.

Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.

Pinker K, Andrzejewski P, Baltzer P, Polanec SH, Sturdza A, Georg D, Helbich TH, Karanikas G, Grimm C, Polterauer S, Poetter R, Wadsak W, Mitterhauser M, Georg P.

PLoS One. 2016 May 11;11(5):e0155333. doi: 10.1371/journal.pone.0155333. eCollection 2016.

10.

Advanced imaging of colorectal cancer: From anatomy to molecular imaging.

García-Figueiras R, Baleato-González S, Padhani AR, Marhuenda A, Luna A, Alcalá L, Carballo-Castro A, Álvarez-Castro A.

Insights Imaging. 2016 Jun;7(3):285-309. doi: 10.1007/s13244-016-0465-x. Epub 2016 Apr 30. Review.

11.

In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation.

Cao J, Campbell J, Liu L, Mason RP, Lippert AR.

Anal Chem. 2016 May 3;88(9):4995-5002. doi: 10.1021/acs.analchem.6b01096. Epub 2016 Apr 15.

12.

Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.

Sharma P, Mukherjee A.

Ann Transl Med. 2016 Feb;4(3):53. doi: 10.3978/j.issn.2305-5839.2016.01.26. Review.

13.

Nanoscale Metal-Organic Frameworks for Ratiometric Oxygen Sensing in Live Cells.

Xu R, Wang Y, Duan X, Lu K, Micheroni D, Hu A, Lin W.

J Am Chem Soc. 2016 Feb 24;138(7):2158-61. doi: 10.1021/jacs.5b13458. Epub 2016 Feb 16.

14.

Feasibility and reproducibility of BOLD and TOLD measurements in the liver with oxygen and carbogen gas challenge in healthy volunteers and patients with hepatocellular carcinoma.

Bane O, Besa C, Wagner M, Oesingmann N, Zhu H, Fiel MI, Taouli B.

J Magn Reson Imaging. 2016 Apr;43(4):866-76. doi: 10.1002/jmri.25051. Epub 2015 Sep 28.

15.

Functional electron paramagnetic resonance imaging of ischemic rat heart: Monitoring of tissue oxygenation and pH.

Gorodetsky AA, Kirilyuk IA, Khramtsov VV, Komarov DA.

Magn Reson Med. 2016 Jul;76(1):350-8. doi: 10.1002/mrm.25867. Epub 2015 Aug 24.

16.

Using semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters to evaluate tumor hypoxia: a preclinical feasibility study in a maxillofacial VX2 rabbit model.

Zheng L, Li Y, Geng F, Zheng S, Yan R, Han Y, Wang Q, Zhang Z, Zhang G.

Am J Transl Res. 2015 Mar 15;7(3):535-47. eCollection 2015.

17.

Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data.

Hormuth DA 2nd, Weis JA, Barnes SL, Miga MI, Rericha EC, Quaranta V, Yankeelov TE.

Phys Biol. 2015 Jun 4;12(4):046006. doi: 10.1088/1478-3975/12/4/046006.

19.

Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.

Heijmen L, ter Voert EE, Oyen WJ, Punt CJ, van Spronsen DJ, Heerschap A, de Geus-Oei LF, van Laarhoven HW.

PLoS One. 2015 Apr 1;10(4):e0120823. doi: 10.1371/journal.pone.0120823. eCollection 2015.

20.

Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.

Mera Iglesias M, Aramburu Núñez D, Del Olmo Claudio JL, López Medina A, Landesa-Vázquez I, Salvador Gómez F, Driscoll B, Coolens C, Alba Castro JL, Muñoz V.

Comput Math Methods Med. 2015;2015:103843. doi: 10.1155/2015/103843. Epub 2015 Feb 19.

Supplemental Content

Support Center